Design Therapeutics, Inc. - DSGN
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 16
Latest filed: Aug 14, 2026
| Form | Count |
|---|---|
| 4 | 7 |
| 8-K | 5 |
| SCHEDULE 13G/A | 2 |
| SCHEDULE 13G | 2 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | — | 0000919574-26-005487 | View |
| Aug 14, 2026 | SCHEDULE 13G | — | 0000919574-26-005202 | View |
| Aug 03, 2026 | 8-K | Aug 03, 2026 | 0001193125-26-329570 | View |
| Jun 11, 2026 | 8-K | Jun 09, 2026 | 0001193125-26-267485 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001193125-26-267732 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001751873-26-000002 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001559570-26-000008 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001754129-26-000006 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001579826-26-000002 | View |
| Jun 11, 2026 | 4 | Jun 09, 2026 | 0001478916-26-000009 | View |
| Jun 09, 2026 | SCHEDULE 13G | — | 0000919574-26-003921 | View |
| May 18, 2026 | 8-K | May 18, 2026 | 0001193125-26-227875 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0000919574-26-003492 | View |
| Apr 28, 2026 | 8-K | Apr 28, 2026 | 0001193125-26-187012 | View |
| Apr 01, 2026 | 4 | Mar 31, 2026 | 0001559570-26-000006 | View |
| Apr 01, 2026 | 8-K | Mar 31, 2026 | 0001193125-26-137861 | View |